Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
6
×
national
6
×
national blog main
biotech
san francisco top stories
clinical trials
fda
national top stories
new york top stories
san francisco blog main
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
europe top stories
indiana blog main
indiana top stories
new york blog main
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
europe blog main
roche
abaloparatide
amgen
amy heimberer
arena pharmaceuticals
artificial intelligence
barrow neurological institute
ben and catherine ivy foundation
What
drug
6
×
medicine
6
×
cancer
fda
approved
marketing
new
patients
alex
alzheimer's
amgen
amgen’s
announced
approval
atrophy
bad
brain
carries
case
ceo
collaboration
daily
deeper
developed
discovery
disease
dna
doses
eisai
entered
europe
european
evrysdi
failed
fight
fingerprint
flags
fortune
friday
genetic
Language
unset
Current search:
drug
×
" life sciences "
×
national
×
medicine
×
@xconomy.com
4 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Pfizer Taps Insilico Medicine to Use AI for Drug Target Discovery
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
5 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues